Chemotherapy-induced recruitment of myeloid-derived suppressor cells abrogates efficacy of immune checkpoint blockade

Pitt, 2016, Resistance mechanisms to immune-checkpoint blockade in cancer: tumor-intrinsic and -extrinsic factors, Immunity, 44, 1255, 10.1016/j.immuni.2016.06.001 Garg, 2015, Immunogenic cell death, Int J Dev Biol, 59, 131, 10.1387/ijdb.150061pa Kanterman, 2014, Adverse immunoregulatory effects of 5FU and CPT11 chemotherapy on myeloid-derived suppressor cells and colorectal cancer outcomes, Cancer Res, 74, 6022, 10.1158/0008-5472.CAN-14-0657 Eriksson, 2016, Gemcitabine reduces MDSCs, tregs and TGFbeta-1 while restoring the teff/treg ratio in patients with pancreatic cancer, J Transl Med, 14, 282, 10.1186/s12967-016-1037-z Vincent, 2010, 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity, Cancer Res, 70, 3052, 10.1158/0008-5472.CAN-09-3690 Alizadeh, 2014, Doxorubicin eliminates myeloid-derived suppressor cells and enhances the efficacy of adoptive T-cell transfer in breast cancer, Cancer Res, 74, 104, 10.1158/0008-5472.CAN-13-1545 Sevko, 2013, Antitumor effect of paclitaxel is mediated by inhibition of myeloid-derived suppressor cells and chronic inflammation in the spontaneous melanoma model, J Immunol, 190, 2464, 10.4049/jimmunol.1202781 Gandhi, 2018, Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer, N Engl J Med, 378, 2078, 10.1056/NEJMoa1801005 Kalathil, 2013, Higher frequencies of GARP(+)CTLA-4(+)Foxp3(+) T regulatory cells and myeloid-derived suppressor cells in hepatocellular carcinoma patients are associated with impaired T-cell functionality, Cancer Res, 73, 2435, 10.1158/0008-5472.CAN-12-3381 Lu, 2019, Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectives, J Hepatocell Carcinoma, 6, 71, 10.2147/JHC.S159693 Greten, 2017, Targets for immunotherapy of liver cancer, J Hepatol, 68, 157, 10.1016/j.jhep.2017.09.007 Liu, 2018, The significance of intertumor and intratumor heterogeneity in liver cancer, Exp Mol Med, 50, e416, 10.1038/emm.2017.165 Zhou, 2018, Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy, Gut, 67, 931, 10.1136/gutjnl-2017-314032 Chan, 2017, Systematic evaluation of circulating inflammatory markers for hepatocellular carcinoma, Liver Int, 37, 280, 10.1111/liv.13218 Chan, 2020, Development of a novel inflammation-based index for hepatocellular carcinoma, Liver Cancer, 9, 167, 10.1159/000504252 Liu, 2020, Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma, Gut, 69, 365, 10.1136/gutjnl-2018-317257 Sun, 2018, An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma, Nat Commun, 9, 5214, 10.1038/s41467-018-07402-8 Menard, 2008, Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity, Cancer Immunol Immunother, 57, 1579, 10.1007/s00262-008-0505-6 Nars, 2013, Immunomodulatory effects of low dose chemotherapy and perspectives of its combination with immunotherapy, Int J Cancer, 132, 2471, 10.1002/ijc.27801 Kerbel, 2004, The anti-angiogenic basis of metronomic chemotherapy, Nat Rev Cancer, 4, 423, 10.1038/nrc1369 Bezu, 2015, Corrigendum: "combinatorial strategies for the induction of immunogenic cell death, Front Immunol, 6, 275 Ardalan, 1992, Phase I study of high dose 5-fluorouracil and high dose Leucovorin with low dose phosphonacetyl-L-aspartic acid in patients with advanced malignancies, Int J Radiat Oncol Biol Phys, 22, 511, 10.1016/0360-3016(92)90864-E Ko, 2009, Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients, Clin Cancer Res, 15, 2148, 10.1158/1078-0432.CCR-08-1332 Wu, 2012, Polysaccharide from Lentinus edodes inhibits the immunosuppressive function of myeloid-derived suppressor cells, PLoS One, 7, 10.1371/journal.pone.0051751 Ko, 2010, Direct and differential suppression of myeloid-derived suppressor cell subsets by sunitinib is compartmentally constrained, Cancer Res, 70, 3526, 10.1158/0008-5472.CAN-09-3278